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Edited by Felix WielandAbstract Nod1 and Nod2 proteins play important roles in
mammalian innate immune responses as intracellular sensors
for bacterial peptidoglycan. Nod1 and Nod2 share structural
homology with many R proteins involved in plant disease
resistance. It has been demonstrated that plant Hsp90 and its
co-chaperone RAR1 are implicated in R-mediated disease resis-
tance. Here the Chp-1 gene encoding a mammalian homologue
of plant RAR1 was identiﬁed as a new target for transcriptional
activation by heat shock factor 1 (HSF1), a stress-responsive
HSF isoform. In addition, Nod1 is demonstrated to be a client
protein of the Hsp90 chaperone complex containing the Chp-1.
Chp-1 interacts with the tetratricopeptide repeat (TPR) domain
of protein phosphatase 5 (PP5) and the ATPase domain of
Hsp90 via two distinct zinc-binding cysteine and histidine rich
domains (CHORDs). These ﬁndings suggest a common
regulatory mechanism involving the Hsp90 chaperone complex
in R-mediated disease resistance in plants and Nod1-mediated
innate immune response in mammals.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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phosphatase 51. Introduction
Heat shock factors (HSFs) are transcription factors con-
served from yeast to humans that play a central role in control-
ling cellular homeostasis in response to stress. The mammalian
stress-responsive HSF isoform, HSF1, is converted from the
inactive monomer to the DNA binding competent homotrimer
in response to a wide range of stresses including heat shock,
oxidative stress, heavy metals, and viral infection [1]. Consis-
tent with the activation of HSF1 by multiple stress conditions,
gene deletion studies have revealed important roles for HSF1
in mouse extra-embryonic development, fertility, mitochon-
drial metabolism, resistance to stress-induced apoptosis, and
inﬂammatory responses [1]. A role for HSF1 in immune
responses has been suggested based on its role in constitutive
expression of many genes related to the immune responseAbbreviations: CHORD, cysteine and histidine rich domains; HSF,
heat shock factor; NOD, nucleotide oligomerization domain; PP5,
protein phosphatase 5; PAMPs, pathogen associated molecular pat-
terns; PRRs, pattern recognition receptors; TPR, tetratricopeptide
repeat
*Fax: +82 2 888 1604.
E-mail address: hahnjs@snu.ac.kr
0014-5793/$30.00  2005 Published by Elsevier B.V. on behalf of the Feder
doi:10.1016/j.febslet.2005.07.024and inﬂammation such as genes encoding interlerukin-6 (IL-
6) and the chemokine CCL5 [2]. Furthermore, HSF1 activates
the transcription of genes encoding protein molecular chaper-
ones that function in antigen presentation and in the instance
of HSPs either derived from pathogens or released from host
cells, in triggering immune responses through cell surface
receptors such as Toll-like receptors [3,4]. Hsp90, a well known
target for gene expression by HSF1, has been demonstrated to
function in immune stimulation in response to bacterial DNA
or synthetic oligonucleotides [5], and in LPS-mediated macro-
phage activation [6].
Recent studies have identiﬁed a role for the Hsp90 chaper-
one complex in plant innate immune responses, which mediate
disease resistance via the action of R (resistance) proteins [7,8].
In the innate immune system, detection of pathogens is medi-
ated by host pattern recognition receptors (PRRs) recognizing
pathogen associated molecular patterns (PAMPs). In plants, R
proteins act as PRRs recognizing molecular events derived
from pathogen molecules encoded by avr (avirulence) genes
[9]. The largest class of R proteins shows structural conserva-
tion, having amino-terminal eﬀector domains consisting of
either a Toll/IL-1 receptor-like (TIR) or coiled-coli (CC)
domain, followed by a central nucleotide binding oligomeriza-
tion domain (NOD), and carboxyl-terminal leucine-rich repeat
(LRR) domain [9–11]. The plant RAR1 and SGT1 proteins,
which interact with each other, have been shown to be essential
in many R protein-mediated immune responses to diverse
plant pathogens [12]. Furthermore, the ﬁnding that both
RAR1 and SGT1 interact with Hsp90 suggests that RAR1
and SGT1 might function as Hsp90 co-chaperones to regulate
the stability and activity of R proteins within diﬀerent regula-
tory networks [13–15]. Indeed Hsp90 has been shown to stabi-
lize several R proteins such as Arabiodopsis RPM1 [14] and
Nicotiana benthamiana RX [16].
In mammals, plasma membrane Toll-like receptors (TLRs)
recognize PAMPs in the extracellular compartment [17],
whereas Nod1 and Nod2 act as intracellular PRRs by sensing
diﬀerent moieties of bacterial peptidoglycan [10,18]. Nod1 and
Nod2, which show structural and functional similarity with
plant R proteins, belong to a recently discovered NOD family
of proteins also known as CATERPILLER (CARD,
transcription enhancer, R (purine)-binding, pyrin, lots of leu-
cine repeats) [10,18]. The NOD family proteins share a con-
served structure that includes variable amino-terminal
eﬀector domains, a NOD domain, and LRR regions that
recognize speciﬁc pathogens. Upon signal recognition, the
NOD domain undergoes homo-oligomerization, followed by
activation of downstream signaling molecules through homo-
philic and non-homophilic protein interactions through eﬀec-
tors domains. Both Nod1 and Nod2 ultimately signal theation of European Biochemical Societies.
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involved in the innate and adaptive immune response, inﬂam-
matory responses, cell survival, and in other functions.
The mammalian genome encodes two identiﬁable plant
RAR1 homologues, Melusin and Chp-1 [19,20]. While the
muscle-speciﬁc Melusin protein has been shown to function
in stress adaptation to mechanical stimuli in heart muscle
[19], the biological function for Chp-1 is not well understood.
Here I demonstrate that the Chp-1 gene is a direct target of
HSF1-mediated stress-induced gene expression. Chp-1 protein
physically interacts with both Hsp90 and an Hsp90 co-chaper-
one, protein phosphatase 5 (PP5), via distinct domains. Fur-
thermore, Nod1 associates with Hsp90 chaperone complex
that include Chp-1, and the stability of Nod1 is regulated by
Hsp90 activity.Fig. 1. HSF1 regulates heat shock induction of Chp-1 gene expres-
sion. (A) Gene expression levels detected by DNA microarray.
Relative mRNA expression levels in wild type (WT) and hsf1 knock-
out (hsf1/) MEF cell lines under 37 C control (C) conditions or
after heat shock at 42 C for 1 h (H) are presented. (B) Detection of
heat shock induction by RT-PCR. The RT-PCR products corre-
sponding to the levels of Hsp70.1, Chp-1, and Hspa5 (quantitation2. Materials and methods
2.1. Plasmids and strains
cDNA clones of mouse Chp-1 (pCMV SPORT6 Chp-1) and
HSP90a (pCMV SPORT6 HSP90a) were purchased from open biosys-
tems, and expression plasmids for various Nod1 and Nod2 proteins
(pcDNA3 Nod1-HA, pcDNA3 Nod1 LRR-HA, pcDNA3-Nod2)
[21] and PP5 (pCDNA3-PP5) [22] were kindly provided by Drs. Gab-
riel Nun˜ez and Naohiro Inohara, and Dr. Xiao-Fan Wang, respec-
tively. The pCMV6 ﬂag-PP5 tetratricopeptide repeat (TPR) plasmids
expressing wild type or mutant form (K32A and R101A) of TPR do-
main of PP5 were kind gift from Dr. Michel Chinkers [23]. pEBG-3x
Chp-1 plasmid expressing GST-Chp1 was constructed by cloning
PCR-ampliﬁed Chp-1 ORF to pEBG-3x. The hsf1/ mouse embry-
onic ﬁbroblast cell lines were kindly provided by Dr. Ivor Benjamin
[24].control) are indicated. (C) The position of HSEs conserved in the
human and mouse Chp-1 promoters are indicated in bold characters
and underlined.2.2. Protein interaction, GST-pull down, and immunoblot analysis
Yeast two-hybrid screening of VP16 library derived from mouse em-
bryos was performed using LexA-Chp-1 as described previously [25].
HEK 293T cells (5 · 106) were transiently transfected with a total of
10 lg of various combinations of expression plasmids. After 24 h of
transfection, cells were lysed in PBS buﬀer containing 0.1% Non-idet
P-40, and 1 mg of cell lysates was subjected to immunoprecipitation
analysis with anti-HA antibody or GST-pull down experiments using
glutathione–agarose (Sigma). The precipitates were analyzed by immu-
noblotting using anti-Hsp90a (Stressgen), anti-Hsp70 (Stressgen), anti-
GST, and anti-HA (Roche) antibodies.2.3. DNA microarray analysis
MEF cells derived from wild type or hsf1 knock-out mouse were
maintained at 37 C or heat shocked at 42 C for 1 h to isolate mRNA.
Gene expression levels were detected by hybridization to Gene-Chip
Murine Genome U74Av2 (Aﬀymetrix). Experiments were indepen-
dently performed in triplicate, and a P value <0.01 was used.3. Results
3.1. Heat shock induction of Chp-1 is regulated by HSF1
To begin to understand the molecular basis for the multiple,
distinct function of HSF1, control and heat-shocked wild type
and hsf1/ embryonic ﬁbroblasts were used as a source for
mRNA in DNA microarray experiments. This microarray
analysis (unpublished data), as well as a previous study [26],
revealed the Chp-1 gene, encoding one of two mammalian
homologues of plant RAR1 proteins, as a new target of mam-
malian HSF1. As shown in Fig. 1A, Chp-1 mRNA levels were
induced by heat shock in wild type mouse embryonic ﬁbro-blasts (MEF) but not in MEF cells derived from HSF1
knock-out mouse [24]. From three independent microarray
analyses, Chp-1 expression was induced by 3.8-fold after 1 h
of heat shock at 42 C. The induction fold was lower than that
of Hsp70.1, a well established direct target of HSF1, but com-
parable to other targets such as Hspca encoding Hsp86
(Fig. 1A). The HSF1-dependent heat shock induction of
Chp-1 was conﬁrmed by RT-PCR (Fig. 1B). Moreover, well
conserved heat shock elements (HSEs), the binding site for
HSF1 [27], were observed in the promoters of both the mouse
and human Chp-1 genes, further supporting the direct HSF1-
mediated stress induction of Chp-1 transcription (Fig. 1C).
3.2. Chp-1 interacts with Hsp90 and protein phosphatase 5
(PP5)
As a ﬁrst step to understand the function of Chp-1 in re-
sponse to stress, Chp-1-interacting proteins were searched by
screening a yeast two-hybrid library generated from mouse em-
bryos using a LexA-Chp-1 fusion protein as bait. All three iso-
lated clones contained the TPR domain of protein phosphatase
5 (PP5) [28]. PP5 is a member of the Hsp90 co-chaperone fam-
ily which interacts with the carboxyl-terminal MEEVD resi-
dues of Hsp90 through its TPR domain [29]. Chp-1 also
interacted with the full length PP5 but not with the isolated
carboxyl-terminal phosphatase domain of PP5 (Fig. 2A).
RAR1, a Chp-1 homologue in plants, has been shown to
Fig. 2. Yeast two-hybrid interactions of Chp-1, Hsp90, and PP5. (A) The PP5 TPR domain interacts with Chp-1. S. cerevisiae strain L40 cells
expressing Chp-1 as a LexA fusion protein and distinct sub-domains of PP5 as VP16 fusion proteins were grown in the absence or presence of
histidine to detect protein-protein interaction. (B) The Hsp90 ATPase domain interacts with Chp-1. Yeast two-hybrid interactions were detected
using cells expressing LexA-fused Chp-1 and VP16-fused Hsp90 derivatives. (C) Hsp90 and PP5 preferentially interact with distinct CHORD
domains of Chp-1. Yeast two-hybrid interactions were detected between the indicated LexA-Chp-1 derivatives and VP16-Hsp90, or LexA-Chp-1
derivatives and VP16-PP5. (D) Conserved residues in the PP5 TPR domain are required for the interaction with Chp-1. Yeast two-hybrid interactions
were detected using cells expressing LexA-Chp1 and wild type (WT) or mutant forms (K32A and R101A) of the PP5 TPR domain fused to VP16.
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Chp-1 can also interact with Hsp90. Mammalian Hsp90 exists
as two separately encoded isoforms, Hsp90a and Hsp90b, with
a high degree of structural and functional homology [30]. Since
their functions are largely indistinguishable, Hsp90a was usedfor the experiments. Yeast two-hybrid analysis showed an
interaction between Chp-1 and the ATPase domain of Hsp90a,
which was also mapped as an interacting domain with plant
RAR1 [13] (Fig. 2B). While this manuscript was in preparation,
the interaction of Chp-1 with the ATPase domain of Hsp90b
4516 J.-S. Hahn / FEBS Letters 579 (2005) 4513–4519was reported [31], supporting the notion that both Hsp90a and
Hsp90b are engaged in interactions with Chp-1.
The interacting regions of Chp-1 with Hsp90 and with PP5
were mapped by yeast two-hybrid analyses. Chp-1 contains
two zinc-binding cysteine and histidine rich domains
(CHORD-I and CHORD-II) and a CS domain (CHORD-con-
taining protein and SGT1) which has homology to the Hsp90
co-chaperone p23 [32]. The Chp-1 CS domain is also present in
SGT1, involved in plant R-mediated disease resistance, but not
in RAR1 [33]. Hsp90 and PP5 showed distinct patterns of
interaction with Chp-1. While Hsp90 interacted most strongly
with the CHORD-II domain of Chp-1 in this assay, PP5 inter-
acted with both the CHORD-I and CHORD-II domains, with
slightly diminished eﬃcacy with CHORD-II (Fig. 2C). Previ-
ously, four basic residues conserved in the TPR domains of
Hsp90-binding co-chaperones were shown to be critical for
PP5 binding to Hsp90 [23]. I examined whether these residues
are also important for PP5 binding to Chp-1. Two PP5 TPR
domain mutants, K32A and R101A, which cannot bind to
Hsp90 [23], do not show an interaction with Chp-1, suggesting
that similar TPR folding is involved in binding to both Hsp90
and to Chp-1 (Fig. 2D). Note that even though the PP5 mutant
TPR domains do not bind to the full length and CHORD-I do-
main of Chp-1, they displayed weak interactions with
CHORD-II. Therefore, PP5 TPR binding to CHORD-II
may be largely mediated by a distinct surface of the PP5
TPR domain.
The interactions among Hsp90, Chp-1, and PP5 were further
conﬁrmed by co-immunoprecipitation experiments with
extracts from HEK (human embryonic kidney) 293T cells.
GST-Chp-1 and PP5-HA fusion proteins were transiently
expressed in 293T cells and the proteins interacting with
GST-Chp-1 were detected by GST pull-down, followed by
immunoblotting. As shown in Fig. 3A, GST-Chp-1 showed
interactions with both PP5-HA and endogenous Hsp90a. I
also examined the interaction of the PP5 TPR domain with
Chp-1 (Fig. 3B). Consistent with the yeast two-hybrid analysis,
GST-Chp-1 interacted with the wild type PP5 TPR domain butFig. 3. Interactions of Hsp90, Chp-1, and PP5 in vivo. (A) Interactions of
transfected with plasmids expressing PP5-HA and GST or GST-Chp-1. G
(input) or precipitates with glutathione–agarose beads (GST pull-down) we
Interactions between GST-Chp-1 and the Flag-PP5 TPR domain. Human 29
wild type or mutant forms of Flag-PP5 TPR (K32A and R101A), and t
immunoblotting.not with either of two independent PP5 TPR domain mutants
(K32A and R101A) which have been shown to be defective in
Hsp90 binding. Furthermore, as expected, neither of these
mutations abrogated the interaction between Chp-1 and
Hsp90.
3.3. Nod1 is a client of the Hsp90 chaperone complex
The interaction of Chp-1 with Hsp90 suggests a functional
similarity of Chp-1 with plant RAR1, which has been shown
to be involved in R protein-mediated plant disease resistance
as a co-chaperone with Hsp90 [13–15]. Among the mammalian
homologues of plant R proteins, Nod1 and Nod2 function sim-
ilarly to R proteins as intracellular sensors recognizing patho-
gens. Therefore, I hypothesized that Hsp90 and Chp-1 might
function in the regulation of Nod1 and Nod2 signaling. Indeed,
co-immunoprecipitation experiments demonstrated that Nod1-
HA interacts with Hsp70 and Hsp90a, suggesting that Nod1 is
an Hsp90 client protein (Fig. 4A). However, the LRR domain
of Nod1 did not bind to Hsp70 or Hsp90a. Interactions with
both Hsp70 and Hsp90 are commonly observed for many
Hsp90 client proteins, since Hsp70 is involved in initial events
in protein folding [30]. In addition to the co-immunoprecipita-
tion experiments, GST pull-down experiments with GST-
Chp-1 showed the presence of both Nod1-HA and Hsp90a in
the GST-Chp-1 precipitates, suggesting that Chp-1 might act
as a co-chaperone for Hsp90 in the maturation of Nod1
(Fig. 4B). However, GST-Chp-1 showed very weak interac-
tions with Hsp70 (Fig. 4B), suggesting that Chp-1 and Hsp90
may participate at later stages of Nod1 maturation after
Hsp70 is released from Nod1, as has been demonstrated for
the maturation of steroid hormone receptors [34].
The interaction between Nod1 and the Hsp90 chaperone
complex strongly suggests that these chaperones play a role
in the stability, maturation, and/or function of Nod1. To
ascertain whether the Hsp90 chaperone complex functions in
the regulation of Nod1, the potent and speciﬁc Hsp90 inhibitor
geldanamycin was used. Geldanamycin inhibits Hsp90 func-
tion by binding to the ATP binding pocket in the ATPasePP5-HA and Hsp90a with GST-Chp-1. Human 293T cells were co-
ST-pull-down experiments were performed and the total cell extracts
re analyzed by immunoblotting (IB) with antibodies as indicated. (B)
3T cells were co-transfected with plasmids expressing GST-Chp-1 and
he cell extracts were subjected to GST pull-down and analyzed by
Fig. 4. Regulation of Nod1 by Hsp90 chaperone complex. (A) Interaction of Nod1 with Hsp70 and Hsp90. Human 293T cells were transfected with
control vector (C), or plasmids expressing HA-tagged Nod1 (Nod1-HA), or the isolated LRR domain of Nod1 (LRR-HA). Cell extracts were
immunoprecipitated with anti-HA antibody and the immunoprecipitates and total cell extracts were analyzed by immunoblotting with the indicated
antibodies. (B) Presence of Nod1 in Hsp90 chaperone complex containing Chp-1. 293T cells were co-transfected with plasmids expressing Nod1-HA
and GST or GST-Chp1. Cell extracts were subjected to GST-pull down followed by immunoblotting. (C) Hsp90 inhibition reduces Nod1 steady-state
levels. Human 293T cells were transfected with pcDNA3 Nod-HA and after 20 h, cells were split into ﬁve plates and incubated further for 6 h. Cells
were treated with the indicated concentrations of geldanamycin for 20 h and total cell extracts were analyzed by immunoblotting using the indicated
antibodies.
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proteins of Hsp90 chaperone complex [34]. As shown in
Fig. 4C, increasing the concentration of geldanamycin added
to cultured 293T cells resulted in signiﬁcant reduction in the
steady state levels of Nod1-HA protein, supporting the
hypothesis that stability of Nod1 is regulated by Hsp90. In
contrast, as previously observed the Hsp90 and Hsp70 protein
levels were increased by geldanamycin treatment, which may
reﬂect increases in transcription mediated by activation of
HSF1 through relieving Hsp90-mediated negative regulation
[35].4. Discussion
4.1. Regulation of Nod1 by Hsp90 chaperone complex
Hsp90 is not required for de novo folding of most proteins,
but it is involved in maturation and stabilization of intermedi-
ately folded proteins as a multichaperone complex in collabo-
ration with Hsp70 and co-chaperones [30,36]. The rapidly
growing members of Hsp90 client proteins include key regula-
tory proteins such as steroid hormone receptors, transcriptionfactors, protein kinases. In relation to its role in cell cycle, cell
growth and diﬀerentiation, and apoptosis, Hsp90 has been
shown to be implicated in pathological conditions including
ischaemia and reperfusion, cancer, and infections [36].
In this study Nod1, a cytoplasmic sensor for bacterial pepti-
doglycan, was identiﬁed as a novel Hsp90 client protein,
suggesting a role for Hsp90 in the regulation of innate immune
responses in mammals. Nod1 and Nod2 were initially identi-
ﬁed as proteins homologous to Apaf-1 (apoptotic protease
activation factor-1), which triggers apoptosis in response to
cytochrome c release from mitochondria [21]. Apaf-1 shares
structural similarity to Nod1 and Nod2 having the amino-
terminal CARD and middle NOD domains [10]. The activation
mechanism of Apaf-1 exhibits similarities to that of Nod1 and
Nod2 in that signal recognition by the carboxyl-terminal
WD40 domain leads to oligomerization of the proteins and
recruitment of downstream eﬀecter molecules through the
CARD domain. It has been shown that both Hsp70 and
Hsp90 bind to Apaf-1 and prevent cytochrome c-mediated olig-
omerization of Apaf-1 and recruitment of procaspase-9 to
Apaf-1 [37–39]. In addition, accumulating evidence suggests
that plant R proteins, having structural and functional
4518 J.-S. Hahn / FEBS Letters 579 (2005) 4513–4519similarity to Nod1 and Nod2, are also regulated by a speciﬁc
Hsp90 isoform [13–15]. Therefore, it can be postulated that a
regulatory mechanism involving Hsp90 is conserved for pro-
teins with structural homology with Nod1.
4.2. Roles of Hsp90 co-chaperones in Nod1 signaling
Hsp90 interacts with a number of co-chaperones which assist
Hsp90 activity in diverse ways such as in regulating the Hsp90
ATPase cycle or in substrate binding [30]. Many of the co-
chaperones bind to the Hsp90 carboxyl-terminal MEEVD
residues through their TPR motifs. The Hsp90 co-chaperones
harboring TPR domain include immunophillins (Cyp40,
FKBP51, and FKBP52) and the protein phosphatase PP5.
On the other hand, co-chaperones such as p23 and Cdc37
can bind directly to Hsp90 without a TPR domain.
Here, I identiﬁed the Chp-1 gene as a target of HSF1, and
demonstrated that Chp-1 interacts with Hsp90 and PP5, sug-
gesting its role as an Hsp90 co-chaperone like its plant homo-
logue RAR1. According to the well studied example of the
maturation process of steroid hormone receptors, Hsp70 is
responsible for the initial folding of receptors by forming early
complex with other co-chaperones. At later stages of matura-
tion, the early complex is replaced by Hsp90 chaperone com-
plex containing p23 and immunophilins [30]. Although Nod1
interacts with Hsp70, only low levels of Hsp70 were detected
in a complex containing Chp-1, Hsp90, and Nod1. Therefore,
Chp-1 and Hsp90 could function in later stages of the Nod1
maturation process after Hsp70 is released from Nod1
(Fig. 5A). Although the CS domain of Chp-1 shows homology
to p23, which inhibits the ATPase activity by binding to theFig. 5. Model for the regulation of Nod1 by Hsp90 chaperone
complex. (A) Proposed model for the regulation of Nod1 by the Hsp90
chaperone complex. Nod1 is initially folded by Hsp70 and its
subsequent stabilization and maturation is mediated by the Hsp90
chaperone complex containing Chp-1. Upon recognition of bacterial
peptidoglycan, Nod1 is activated by multimerization through NOD
domains. The release of the Hsp90 chaperone complex upon activation
occurs for other Hsp90 client proteins such as hormone receptors but
has not been demonstrated for Nod1. (B) Schematic diagram of Hsp90
chaperone complexes for Nod1 regulation in mammals and for the
regulation of R-mediated disease resistance in plants. The double-
headed arrow indicates that the PP5 TPR domain can interact both
with CH-I of Chp-1 and the carboxyl terminus of Hsp90. It has been
shown that CS domain of SGT1 is involved in interaction with Hsp90
in plants and mammals, but the binding domain in Hsp90 has not been
identiﬁed [13,40]. CH1, CHORD-I domain; CH-II, CHORD-II
domain; CS, motif in CHORD-containing protein and SGT1; TPR,
tetratricopeptide repeat domain; SGS, SGT1-speciﬁc motif.dimerized ATPase domains of Hsp90, it is not clear yet
whether Chp-1 shares a function similar to that of p23. A re-
cent study demonstrated that unlike p23, which binds to
Hsp90 in the presence of ATP, Chp-1 can bind to Hsp90 in
an ATP-independent manner [31].
I also identiﬁed PP5, another Hsp90 co-chaperone, as an
interacting protein with Chp-1. PP5, a member of serine/thre-
onine protein phosphatase, has been shown to be involved in
several stress-responsive signaling pathways regulating cell cy-
cle and apoptosis, and other variety of functions [22,29]. While
the Hsp90 binding site was mapped to the CHORD-II domain
of Chp-1, PP5 bound to CHORD-I domain of Chp-1 through
its TPR domain, suggesting the possibility that Chp-1 can
bridge PP5 and Hsp90. Fig. 5B summarizes the interactions
of Hsp90 with Chp-1 and PP5 identiﬁed in this study and of
the Hsp90 chaperone complex consisting of RAR1 and
SGT1, which is engaged in plant R-mediated disease resistance
[13,33]. Although the interactions are not strictly conserved,
similar domains and domain–domain interactions are involved
in generating multiple chaperone complexes. While further
investigation will be necessary to elucidate the precise roles
for Chp-1 and PP5 in the regulation of Nod1 activity, these
observations suggest that dynamic interactions of various
Hsp90 co-chaperones might play important roles in regulation
of Nod1 signaling.Acknowledgments: I thank Dr. Dennis J. Thiele for helpful discussions
and careful reading of this paper. I also thank Dr. Ivor Benjamin for
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